U.S. Stock News

BXP (BXP) is back on investor radars after recent price weakness, with the stock showing declines over the past week, month, and past 3 months that contrast with its positive 3-year total return. See our latest analysis for BXP. At a share price of US$64.77, BXP has seen weaker short term share price returns this year, including a 12.58% 3 month share price decline. Its 3 year total shareholder return remains positive at 6.65%, suggesting recent momentum has faded compared with its longer...

Piper Sandler’s renewed Overweight view on Tyra Biosciences (TYRA) centers on dabogratinib’s potential across FGFR3-driven conditions, highlighting 2026 data readouts in achondroplasia and bladder cancer, along with recent leadership hires that are now in sharper focus. See our latest analysis for Tyra Biosciences. Tyra’s share price has seen strong momentum recently, with a 16.22% 1 month share price return and a 107.21% 3 month share price return. The 1 year total shareholder return of...

The U.S. administration’s decision to call off planned tariffs on European allies, following talks in Davos, pulled trade tensions off center stage and lifted interest in technology names such as CTS (CTS). See our latest analysis for CTS. At a share price of US$50.18, CTS has recently seen a 1-day share price return of 0.90%, a 30-day share price return of 12.89%, and a 90-day share price return of 23.87%, while its 1-year total shareholder return of 1.35% decline contrasts with 3-year and...

Interest in Harmony Biosciences Holdings (HRMY) has picked up as investors focus on its revenue and earnings growth, its solid financial position, and chart patterns that some traders view as supportive for potential future price strength. See our latest analysis for Harmony Biosciences Holdings. At a share price of US$37.36, Harmony Biosciences has a 90 day share price return of 26.05%. However, the 1 year total shareholder return of 2.33% decline and 3 year total shareholder return of...

Indivior Pharmaceuticals, Inc. recently completed its move of corporate headquarters to the US, creating a new Delaware-based parent while closing a prior US$80.46 million ESOP-related shelf registration and filing a new US$569.10 million ESOP-focused shelf for common stock. This restructuring not only concentrates governance and financing in the company’s largest market but also simplifies reporting, lending arrangements and future equity-based employee programs. We will examine how...

Vaxart, Inc. recently reported in npj Vaccines that its double-blind, placebo-controlled Phase 1 trial of a single-dose oral bivalent norovirus vaccine in breastfeeding women showed vaccine-induced functional norovirus-specific antibodies in maternal breastmilk and serum, as well as norovirus-specific IgA in the stool of their breastfed infants, with the vaccine remaining safe and well tolerated. The finding of a positive correlation between breast milk IgA levels and infant stool IgA offers...

In recent days, Antero Resources has drawn attention as heavy call-option trading coincided with reports that Winter Storm Fern could disrupt US natural gas production and pipeline operations. Investor interest has also been reinforced by insider share purchases and ongoing analyst coverage, underscoring how short-term weather risks can quickly reshape sentiment toward natural gas producers. We’ll now examine how this options surge against the backdrop of Winter Storm Fern could shape...

Hexcel (HXL) is back in focus after its third quarter fiscal 2025 earnings, where defense and space sales rose 11.7% year over year and management authorized US$600 million in share repurchases. See our latest analysis for Hexcel. Hexcel’s share price has climbed 7.74% over the past month and 12.93% over 90 days to US$82.02, while its 1 year total shareholder return of 23.57% and 5 year total shareholder return of 90.78% indicate momentum that recent earnings and the new buyback appear to...

Callaway Golf (CALY) is back in focus after launching its Quantum line of clubs and reintroducing itself under a refreshed corporate name and ticker. Together, these changes reshape how investors may view the business. See our latest analysis for Callaway Golf. Those product launches and the refreshed Callaway Golf identity come after a strong run in the shares, with a 30 day share price return of 31.01% and a 1 year total shareholder return of 90.82%, even though the 3 year and 5 year total...

In January 2026, DXC Technology announced a partnership with Ripple to integrate digital asset custody, tokenization, and programmable payment capabilities into DXC’s Hogan core banking platform, which supports more than 300 million deposit accounts and over US$5.00 trillion in deposits worldwide. This move effectively connects traditional core banking infrastructure with regulated blockchain-based services, giving banks and fintechs an enterprise-scale route to offer digital asset products...

Stewart Information Services recently received an upgrade to an “Outperform” rating from Keefe, Bruyette & Woods, reflecting increased analyst confidence in the company’s prospects. Alongside this change in analyst stance, Stewart has also scheduled its fourth quarter and full-year 2025 earnings call for early February 2026, adding a fresh information catalyst for investors. With analyst sentiment turning more positive, we’ll now examine how this upgrade shapes Stewart Information...

Vistra (NYSE:VST) has entered a multi year nuclear power supply agreement with Meta Platforms to serve its expanding AI focused data centers. The company is carrying out what it describes as the largest corporate supported nuclear uprate program in history to increase nuclear capacity. Together, these moves position Vistra as a key power provider to large scale technology clients that require reliable, carbon free electricity. Vistra shares recently closed at $158.81, with a 1 year return...

Earlier this year, H.C. Wainwright reiterated a positive rating on Kodiak Sciences, expressing confidence in upcoming clinical trial readouts for its retinal disease candidates tarcocimab and KSI-101, following the company’s approximately US$184,000,000 capital raise. The combination of anticipated Phase 3 and Phase 1b data and strengthened funding highlights how Kodiak is positioning its biopolymer platform to potentially reduce treatment burden in conditions like wet age-related macular...

Vera Therapeutics (VERA) is back on investors’ radar after Voya Investment Management’s Voya MidCap Opportunities Fund cited the stock as a top contributor, following successful phase three kidney disease trial results and progress in AI enabled drug discovery. See our latest analysis for Vera Therapeutics. The recent clinical success and AI enabled pipeline work have kept Vera Therapeutics in focus, even as the 1 month share price return of 11.87% decline contrasts with a strong 90 day share...

Why Hub Group is on investors’ radar today Hub Group (HUBG) has caught investor attention after recent share price moves, with the stock last closing at $47.56. That puts fresh focus on how its returns and fundamentals line up. See our latest analysis for Hub Group. That recent 30 day share price return of 8.19%, building on a 33.11% move over 90 days, sits alongside a 1 year total shareholder return of 5.06% and 5 year total shareholder return of 79.48%. This suggests momentum has picked up...

First Bancorp recently reported its fourth-quarter and full-year 2025 results, with net interest income rising to US$106.2 million in the quarter and full-year net income reaching US$111.05 million. An interesting detail is that higher loan loss provisions tied to US$303.2 million of loan growth and hurricane-related reserve changes occurred alongside much stronger earnings per share from continuing operations. We’ll now explore how this stronger profitability, despite higher loan loss...

Arbor Realty Trust: Recent Returns Put Income Focus in the Spotlight Arbor Realty Trust (ABR) shares have faced pressure recently, with negative total returns over the past year and past 3 months. This has prompted many income focused investors to reassess how they view this mortgage REIT. See our latest analysis for Arbor Realty Trust. With the share price at $7.70, recent weakness has been pronounced, with a 90 day share price return of a 34.47% decline and a 1 year total shareholder return...

Klarna Group (NYSE:KLAR) is facing multiple securities class action lawsuits tied to its September 2025 IPO filings. Investors allege the company misrepresented credit loss reserves and lending practices, particularly around its buy now, pay later offering. The cases focus on whether Klarna adequately disclosed credit risk at the time of listing. Klarna Group, trading at $27.11, is coming under legal and investor scrutiny at the same time its shares have seen a 6.5% decline over the past...

BancFirst Corporation reported fourth-quarter 2025 net income of US$59.5 million, up from US$56.48 million a year earlier, with both basic and diluted earnings per share from continuing operations also higher year-on-year. This capped a fifth consecutive year of record net income and earnings per share, supported by the acquisition of American Bank of Oklahoma and very low net charge-offs of US$1.6 million, equal to just 0.02% of loans. We’ll examine how this fifth straight year of record...

Corning (GLW) is heading into a closely watched earnings report, with investors focused on three key areas: the profitability of the Display segment, progress in the optical and specialty businesses, and what recent analyst updates imply for expectations. See our latest analysis for Corning. Corning’s share price has been firming over recent months, with a 30 day share price return of 6.01% and a 90 day share price return of 9.86%. Its 1 year total shareholder return of 95.35% and 5 year...

Recent downgrades on ABM Industries (ABM) have focused on how the WGNSTAR acquisition could constrain capital deployment and margin expansion, particularly by limiting the scope for stock buybacks that some investors were watching. See our latest analysis for ABM Industries. The latest downgrades and the WGNSTAR acquisition come after a period where the 1 month share price return of 6.89% contrasts with a 1 year total shareholder return of 12.08% decline. This hints at some recent momentum...

Why Ellington Financial Matters for Income Focused Investors Ellington Financial (EFC) has been drawing fresh attention as investors reassess mortgage focused real estate investment trusts, with its share price, recent return profile, and income characteristics all coming under closer review. See our latest analysis for Ellington Financial. At a last close of $13.86, Ellington Financial’s recent share price return has been relatively muted in the very short term. Its 1 year total shareholder...

Parker-Hannifin’s Board of Directors recently declared a regular quarterly cash dividend of US$1.80 per share, payable on March 6, 2026, to shareholders of record as of February 6, 2026, marking the company’s 303rd consecutive quarterly dividend. This payout extends Parker-Hannifin’s record of increasing annual dividends for 69 consecutive fiscal years, placing it among the longest-running dividend-growth streaks in the S&P 500 and reinforcing its income-focused appeal as analysts anticipate...

What STERIS Stock’s Recent Moves Signal for Investors STERIS (STE) has caught investor attention after recent share price moves, including a 1 day return of 1.39%, a modest pullback over the past week, and positive performance over the month and past 3 months. See our latest analysis for STERIS. At a share price of $263.13, STERIS has paired a 9.09% 3 month share price return with a 19.81% 1 year total shareholder return, which indicates that recent momentum has been building on an already...